| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |